Атькова Евгения Львовна

Атькова Евгения Львовна

Auto-generated profile, based on publicly available information

Атькова Евгения Львовна

Krasnov Research Institute of Eye Diseases

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Saudi Journal of Ophthalmology
Verified
Journal Article
Open access
EAE.L. Atkova
E.L. Atkova
AFA.A. Fedorov
A.A. Fedorov
ARA.O. Root
A.O. Root
SIS.D. Iartsev
S.D. Iartsev
NKN.N. Krakhovetsky
N.N. Krakhovetsky
VYVasiliy Yartsev
Vasiliy Yartsev
To study the antifibrotic effectiveness of mitomycin-C in the tissues of the ostium site after it application for endonasal endoscopic dacryocystorhinostomy. The study included 45 patients (48 cases) with primary obstruction of the nasolacrimal duct. All patients underwent endoscopic endonasal dacryocystorhinostomy (EEDCR). At the final stage of the operation, a swab with MMC was placed in the region of the formed ostium at a concentration of 0.2 mg/ml for 3 min. An ostium was not intubated. After that, biopsies of the mucous of the nasal cavity and lacrimal sac were performed to study the morphological changes that occur in the tissues overtime, as well as to calculate the concentration of the drug in the tissues. According to the chemical analysis, the concentration of MMC immediately after application was 0.626 ± 0.176 μg/g; after 30 min the concentration of the drug was reduced to 0.23 ± 0.06 μg/g; a day after the operation the drug was not found in the tissue samples. Morphological study established that the repair processes occurring in the mucosa of the nasal cavity and the lacrimal sac after EEDCR are similar to the reparative processes without the use of MMC. The effectiveness of surgical treatment: "positive results" - 77.1% of cases, "relapses" - 22.9% of cases. Application of MMC for prevention of excessive scarring after EEDCR is impractical as it is not possible to achieve antifibrotic concentration of the drug at dacryocystorhinostomy ostium site using this method.

20 December 2021 in International Archives of Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
VYVasiliy Yartsev
Vasiliy Yartsev
EAEugenia L. Atkova
Eugenia L. Atkova
EREugeniy O. Rozmanov
Eugeniy O. Rozmanov
NYNina D. Yartseva
Nina D. Yartseva
Introduction Studying the state of the nasal cavity and its sinuses and the morphometric parameters of the inferior nasal conchae, as well as a comparative analysis of obtained values in patients with primary (PANDO) and secondary acquired nasolacrimal duct obstruction (SALDO), is relevant. Objective To study the rhinological status of patients with PANDO) and SALDO). Methods The present study was based on the results of computed tomography (CT) dacryocystography in patients with PANDO (n = 45) and SALDO due to exposure to radioactive iodine (n = 14). The control group included CT images of paranasal sinuses in patients with no pathology (n = 49). Rhinological status according to the Newman and Lund-Mackay scales and volume of the inferior nasal conchae were assessed. Statistical processing included nonparametric statistics methods; χ2 Pearson test; and the Spearman rank correlation method. Results The difference in values of the Newman and Lund-Mackay scales for the tested groups was significant. A significant difference in scores by the Newman scale was revealed when comparing the results of patients with SALDO and PANDO. Comparing the scores by the Lund-Mackay scale, a significant difference was found between the results of patients with SALDO and PANDO and between the results of patients with PANDO and the control group. Conclusion It was demonstrated that the rhinological status of patients with PANDO was worse than that of patients with SALDO and of subjects in the control group. No connection was found between the volume of the inferior nasal conchae and the development of lacrimal duct obstruction. The present paper has never been presented at any conferences. The present work complies with the institutional ethical standards and with the 1964 Helsinki Declaration and its later amendments. All participants of the present study have given their written informed consent for the research and for publication. The results were analyzed retrospectively. All available data can be obtained by contacting the corresponding author. The present work has received the ethical approval from the Biomedical Ethics Committee of the Scientific Research Institute of Eye Diseases. Received: 15 September 2020 Accepted: 14 February 2021 Article published online: 20 December 2021 © 2021. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

21 February 2018 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
EAE. L. At'KOva
E. L. At'KOva
НКНиколай Николаевич Краховецкий
Николай Николаевич Краховецкий
VYVasiliy Yartsev
Vasiliy Yartsev
ASAnastasia Subbot
Anastasia Subbot
AGAnna Gabashvili
Anna Gabashvili
ДРДенис Алексеевич Рейн
Денис Алексеевич Рейн
Background: One of the main reasons of failure in surgical treatment of primary acquired nasolacrimal duct obstruction is excessive postoperative scarring of the dacryostomy. Despite the variety of procedures designed to prevent this, conflicting evidence of their efficacy and safety provide incentive for further research of antifibrotic therapeutics for adjunctive use in dacryocystorhinostomy.Aims: To evaluate the antifibrotic effect of pirfenidone on human nasal mucosal fibroblast cell culture.Materials and methods: Human nasal mucosal fibroblast cell cultures were established using samples obtained from 3 consecutive patients undergoing endonasal endoscopic dacryocystorhinostomy. Cell viability following treatment with pirfenidone was evaluated using MTS-assay. Induced inhibition of cell proliferation and migration was determined using scratch wound assay.Results: In this study pirfenidone exhibited a significant dose-dependent inhibiting effect on fibroblast proliferation with insignificant cell toxicity. Cell viability following 48 hours of incubation with various pirfenidone concentrations did not drop below 80%. The recovery of the fibroblast monolayer assessed after 24 hours of incubation was 84.88 and 8.26% in the control group, at a drug concentration of 0.15 mg/ml. Cell proliferation and migration was severely inhibited in cell culture specimens treated with pirfenidone compared to controls. The difference between groups was statistically significant (p=0,001).Conclusions: In our study pirfenidone demonstrated a pronounced antifibrotic effect. It is unlikely that inhibition of proliferation and migration of human nasal mucosal fibroblasts is mediated by cell toxicity of this medication as it was evaluated as low. Nonetheless an in vitro analysis is insufficient to judge pirfenidone’s efficacy and safety in preventing cicatrix formation following dacrycystorhinostomy.

9 November 2023 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
EAE.L. Atkova
E.L. Atkova
VYVasiliy Yartsev
Vasiliy Yartsev
MEM.A. Ekaterinchev
M.A. Ekaterinchev
NSN.YU. Shkolyarenko
N.YU. Shkolyarenko
Несмотря на очевидный интерес к процессу, проходящему в слезоотводящих путях при нарушении их проходимости, в литературе представлено немного работ, имеющих своей целью измерение волюметрических параметров слезоотводящих путей. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучение биометрических характеристик слезоотводящих путей в норме и при дакриостенозе. МАТЕРИАЛ И МЕТОДЫ В исследование включены 81 случай дакриостеноза и 38 случаев без патологии слезоотведения. Проводили компьютерную томографию с контрастированием слезоотводящих путей. Анализ биометрических параметров включал определение длины, объема и средней площади среза носослезных протока и канала. Рассчитывали отношение R4/16l (где R — радиус носослезного протока; l — длина носослезного протока). Распределение величин оценивали при помощи теста Шапиро—Уилка. Межгрупповые различия оценивали при помощи теста Манна—Уитни и t-статистики для независимых выборок. Корреляционный анализ проводили по методу Спирмена. Проводили ROC-анализ. Различия считали значимыми при p≤0,05. РЕЗУЛЬТАТЫ Значимыми были различия в объеме (p=0,004) и средней площади среза носослезного протока (p=0,014), а также длине носослезного канала (p=0,034). Установлена взаимосвязь между возрастом обследуемого без патологии слезоотведения и длиной носослезного канала (p=0,042); длиной носослезного канала и объемом носослезного протока (p=0,034), а также объемом носослезного протока и носослезного канала при дакриостенозе (p=0,017). AUC-отношения R4/16l при ROC-анализе составила 0,653 (p=0,007). ЗАКЛЮЧЕНИЕ Помимо очевидных различий обнаружено, что длина носослезного канала у обследуемых обеих групп достоверно различается. Мы рассматривали слезоотводящие пути как гидродинамическую систему, подчиняющуюся закону Пуазейля, поэтому вычисляли отношение R4/16l. Значение этого отношения было различным (p=0,016), ROC-анализ показал высокую чувствительность и специфичность критерия. Это дает возможность использовать данное отношение как диагностический критерий дакриостеноза.

31 December 2019 in Ophthalmology Reports
Verified
Journal Article
Open access
PDF file
OZOleg V. Zhukov
Oleg V. Zhukov
EAEvgenia L. At’kOva
Evgenia L. At’kOva
NKNikolay N. Krakhovetskiy
Nikolay N. Krakhovetskiy
АЛАтькова Евгения Львовна
Атькова Евгения Львовна
Causes of the recurrence after dacryocystorhinostomy are errors during surgery (small size of the bone window, wrong localization of the dacryostomy (too high or too low); inadequate formation of flaps at the medial wall of the lacrimal sac and at the mucosa of the nasal cavity) or problems occurring in the follow-up period (granulation in ostium area, synechiae between the structures of the nasal cavity near the dacryostomy, canaliculi ostium obliteration). A literature review considers various methods of dacryocystitis recurrence treatment both with external and endonasal approaches. In published studies, promising results were obtained using balloon dacryoplasty in the dacryostomy area after dacryocystitis relapse.

1 January 2022 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
EAE.L. Atkova
E.L. Atkova
AMA.A. Maydanova
A.A. Maydanova
NKN.N. Krakhovetskiy
N.N. Krakhovetskiy
LRL.V. Reznikova
L.V. Reznikova
Обзор литературы посвящен описанию этиологических факторов развития стеноза слезной точки, современным методам его диагностики, а также консервативного и хирургического лечения. Представленный анализ основан на изучении данных отечественных и зарубежных литературных источников, в которых изложены сведения как о рутинных, так и о высокотехнологичных методах обследования и лечения пациентов со стенозом слезной точки. Особое внимание уделено различным аспектам проведения наиболее распространенного хирургического вмешательства при данной патологии — пунктопластики.